Study the effect of Atenolol drug in kidneys of Adult Swiss white mice
Article Sidebar
Main Article Content
Abstract
In this study (40) mice were used from both sexes male and female and divided into experimental group and control, used (10) mice for each group treated with atenolol drug and (10) mice as a control group, and the therapeutic doses of the drug determined in three concentrations (0.02, 0.04, and 0.07 mg/Kg) the drug given orally by gavage once daily for month, after that the animals dissected and the blood sample were taken by heart puncture, for measurement the concentration of total creatinine, and also kidney taking for histological study. The results showed significant increases in concentration of creatinine in two doses (0.04 and 0.07 mg/Kg) when compared with control group. In addition to presence of many histological damaging in kidney tissue, such as necrosis of cell lining tubule, heamorrhage and congestion have spreaded in tissue, as well as damaging in glomerulus.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1- Murali, K. B.; Praveen, K.U.; Swarna, L. M. and Shashidhar, R. R. (2013). Formulation & Development of Film Coated Tablets of Atenolol. International Journal of pharmaceutical innovation. 3(3): 90
2- Chopra, H.K.; Krishna, C.K.; Ravinder, S. S. and Komal, K.K. (2009). Non-cardiac Effects of Atenolol. Supplement of JAPI. 57.
3- Bangalore, S.; Messerli, F.H. and Kostis, J.(2007) B- cardiovascular protection using betablockers.J. Am .coll. cardiol. 50: 563-572.
4- Reid, J.L. (2001). Lecture notes on clinical pharmacology. 6. Blackwell Science.pp:76. 5- Pritchett, A.M. and Redfield, M.M. (2002). "Beta-blockers: new standard therapy for heart failure". Mayo Clin. Proc. 77 (8): 839–46.
7- Young, D.S. (1995). Effect of drugs on clinical laboratory tests, 4thed . Pp: 3-190 a 3-211.
8- Krishna, V. (2004). Text Book of pathology, printed in Indian by Offset Himayatnager, Hyderatbad 500029 (A.P.) India, Pp: 538, 564, 573.
10- Brezis, M.; Rosen, S. and Epstein, F. H. (1991). Acute Renal Failure, in Brenner BM, Rector FJ (eds): The Kidney, 4th ed. Philadelphia, pp: 993-1061.
11- Morrissey, S.E.; Nweth, T.; Rees, R.; Barr, A.; Shora, F. and Laycock, J.F. (2001). Renal effect of recombinant prolactin in anaesthetized rat. Eur. J. Endocrinal.145-671. 12- Mabrouk, A. and Cheikh , H. B. (2016). Thymoquinone ameliorates lead-induced suppression of the antioxidant system in rat kidneys . Environ Sci Pollut Res Int., 23:12206-12215.